Catalyst Wire Dossier Catalyst Wire Dossier

BILR 355 (SDS)

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BILR 355 (SDS), covering 2014-10-01 to 2014-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers [Phase 1]

See pricing